Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma

Summary

The purpose of this study is to determine whether an increase in the dose of carboplatin in treatment of advanced intraocular (group C and D) retinoblastoma helps in avoiding radiotherapy and improves the rate of globe salvage.

Timeline

Start

2009-04

Primary completion

2012-04

Completion

2012-04

Publications

• Meel R, Bakhshi S, Pushker N, Vishnubhatla S. Randomized, controlled trial in groups C and D retinoblastoma. Ophthalmology. 2015 Feb;122(2):433-5. doi: 10.1016/j.ophtha.2014.09.013. Epub 2014 Oct 22. No abstract available.

Drugs

Indications